Featured Publications
Ready, willing and able: a model to explain successful use of feedback
Garino A. Ready, willing and able: a model to explain successful use of feedback. Advances In Health Sciences Education 2019, 25: 337-361. PMID: 31598884, DOI: 10.1007/s10459-019-09924-2.Peer-Reviewed Original ResearchPublish or Perish: A Cross-Sectional, Bibliometric Analysis of Physician Assistant Faculty Publications
Garino A, Wang L, Min EA. Publish or Perish: A Cross-Sectional, Bibliometric Analysis of Physician Assistant Faculty Publications. The Journal Of Physician Assistant Education 2022, 33: 87-93. PMID: 35427260, DOI: 10.1097/jpa.0000000000000417.Peer-Reviewed Original ResearchConceptsInclusion criteriaThe Commoditization of Clinical Rotations
Fankhanel C, Brissette D, Garino A. The Commoditization of Clinical Rotations. The Journal Of Physician Assistant Education 2022, 33: 76-77. PMID: 35511470, DOI: 10.1097/jpa.0000000000000416.Peer-Reviewed Original ResearchHumansPhysician AssistantsSet the World on Fire: Sparking Research Interest in Physician Assistants
Garino A. Set the World on Fire: Sparking Research Interest in Physician Assistants. The Journal Of Physician Assistant Education 2014, 25: 21-25. PMID: 25650879, DOI: 10.1097/01367895-201425030-00005.Peer-Reviewed Original Research
2023
Barriers to Research: A National Survey of Physician Assistant Faculty
Lolar S, Welch R, Garino A. Barriers to Research: A National Survey of Physician Assistant Faculty. The Journal Of Physician Assistant Education 2023, 34: 20-27. PMID: 36630214, DOI: 10.1097/jpa.0000000000000480.Peer-Reviewed Original Research
2014
Cancer Education in Physician Assistant Programs
Polansky M, Ross AC, Coniglio D, Garino A, Hudmon KS. Cancer Education in Physician Assistant Programs. The Journal Of Physician Assistant Education 2014, 25: 4-11. PMID: 24765804, DOI: 10.1097/01367895-201425010-00001.Peer-Reviewed Original ResearchConceptsPrimary care rotationCancer educationCare rotationPhysician assistant (PA) programsPrevention/screeningLong-term sequelaeManagement of patientsPA programsCross-sectional studyCancer/palliative careDirect patient carePA schoolIdentification/managementAssistant programsOncologic emergencyInitial diagnosisCancer survivorsCancer treatment effectsPalliative careCancer careCancer surveillanceCancer preventionTeam-based learningCase-based learningPA competency
2011
Effectiveness of a shortened, clinically engaged anatomy course for physician assistant students
Rizzolo LJ, Rando WC, O'Brien MK, Garino A, Stewart WB. Effectiveness of a shortened, clinically engaged anatomy course for physician assistant students. Anatomical Sciences Education 2011, 4: 64-70. PMID: 21337718, DOI: 10.1002/ase.204.Peer-Reviewed Original Research
2006
Anticipation in families with Hodgkin's and non-Hodgkin's lymphoma in their pedigree
Alexandrescu DT, Garino A, Brown-Balem KA, Wiernik PH. Anticipation in families with Hodgkin's and non-Hodgkin's lymphoma in their pedigree. Leukemia & Lymphoma 2006, 47: 2115-2127. PMID: 17071485, DOI: 10.1080/10428190600724928.Peer-Reviewed Original ResearchConceptsHodgkin's lymphomaMean anticipationGeneration of lymphomasDisease-free survivalEnd Results ProgramUS National Cancer InstituteAge of onsetNational Cancer InstituteNHL groupSEER populationSurveillance EpidemiologyResults ProgramMean ageCancer InstituteLymphomaNHLEarly onsetHodgkinUnpublished familiesAgeParent-child pairsRank testChildrenUnreported familiesOnset
2004
Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma
Nanus DM, Garino A, Milowsky MI, Larkin M, Dutcher JP. Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma. Cancer 2004, 101: 1545-1551. PMID: 15378501, DOI: 10.1002/cncr.20541.Peer-Reviewed Original ResearchConceptsSarcomatoid renal cell carcinomaRenal cell carcinomaCell carcinomaAntitumor activityGemcitabine-based regimensGrade 4 toxicityModest antitumor activitySite of metastasisSite of diseaseCombination of doxorubicinInstitutional review boardStable diseaseMedian durationMedian survivalPartial responseRecurrent diseaseComplete responseActive chemotherapyFactor supportMedian timeDuct carcinomaProspective InvestigationInterleukin-2PatientsGemcitabine